Seminars in Nuclear Medicine
Volume 35, Issue 2 , Pages 100-115, April 2005

Clinical applications of 99mTc-sestamibi scintimammography

  • Raymond Taillefer, MD (FRCP(C), ABNM)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Raymond Taillefer, MD, FRCP(C), ABNM, Department of Nuclear Medicine, Hotel-Dieu du CHUM, 3840 St-Urbain, Montréal H2W 1T8, Canada.

Department of Nuclear Medicine, Hotel-Dieu du CHUM, Montréal, Canada.

Mammography is the imaging modality of choice in detection of early, nonpalpable breast cancer. However, scintimammography may prove to be a very useful adjunct to a nondiagnostic or difficult mammography. Future prospective studies will have to be designed so that the specific clinical applications of scintimammography will be well defined. To be clinically relevant, each niche where scintimammography is potentially indicated should be clearly evaluated and incorporated into an algorithm of investigation of breast cancer, taking into consideration the relative advantages and limitations of scintimammography. Special care to obtain high-quality scintimammographic studies is mandatory. Because poor quality studies may be the major drawback, the nuclear medicine community should remind the lesson learned from radiologic mammography. Furthermore, it is also hoped that significant improvement in the scintigraphic equipment and data acquisition will be seen in a very near future to have more widespread clinical diagnostic applications of scintimammography.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(04)00074-1

doi:10.1053/j.semnuclmed.2004.11.002

Seminars in Nuclear Medicine
Volume 35, Issue 2 , Pages 100-115, April 2005